These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 37910593)
1. Perioperative daptomycin for prophylaxis of vancomycin-resistant Enterococcus infection in colonized liver transplant recipients. Mak JT; Ha S; Perloff S; Knorr JP Transpl Infect Dis; 2024 Feb; 26(1):e14186. PubMed ID: 37910593 [TBL] [Abstract][Full Text] [Related]
2. Daptomycin perioperative prophylaxis for the prevention of vancomycin-resistant Enterococcus infection in colonized liver transplant recipients. Sarwar S; Koff A; Malinis M; Azar MM Transpl Infect Dis; 2020 Jun; 22(3):e13280. PubMed ID: 32216015 [TBL] [Abstract][Full Text] [Related]
3. Comparison of risk factors and outcomes of daptomycin-susceptible and -nonsusceptible vancomycin-resistant Enterococcus faecium infections in liver transplant recipients. Lewis JD; Barros AJ; Sifri CD Transpl Infect Dis; 2018 Jun; 20(3):e12856. PubMed ID: 29427322 [TBL] [Abstract][Full Text] [Related]
4. Importance of daptomycin dosage on the clinical outcome in liver transplant recipients with vancomycin-resistant enterococci infection. Lee IK; Sng YP; Li WF; Chen CL; Wang CC; Lin CC; Chen IL J Chemother; 2022 Oct; 34(6):367-374. PubMed ID: 35075978 [TBL] [Abstract][Full Text] [Related]
5. The clinical and molecular epidemiology of pre-transplant vancomycin-resistant enterococci colonization among liver transplant recipients. Banach DB; Peaper DR; Fortune BE; Emre S; Dembry LM Clin Transplant; 2016 Mar; 30(3):306-11. PubMed ID: 26780305 [TBL] [Abstract][Full Text] [Related]
6. A single-center experience with infections due to daptomycin-nonsusceptible Enterococcus faecium in liver transplant recipients. Lewis JD; Enfield KB; Cox HL; Mathers AJ; Sifri CD Transpl Infect Dis; 2016 Jun; 18(3):341-53. PubMed ID: 26953719 [TBL] [Abstract][Full Text] [Related]
7. Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia. Kirkizlar TA; Akalin H; Kirkizlar O; Ozkalemkas F; Ozkocaman V; Kazak E; Ozakin C; Bulbul EN; Ozboz ES; Ali R Leuk Res; 2020 Dec; 99():106463. PubMed ID: 33130331 [TBL] [Abstract][Full Text] [Related]
8. Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia. Hefazi M; Damlaj M; Alkhateeb HB; Partain DK; Patel R; Razonable RR; Gastineau DA; Al-Kali A; Hashmi SK; Hogan WJ; Litzow MR; Patnaik MM Transpl Infect Dis; 2016 Dec; 18(6):913-920. PubMed ID: 27642723 [TBL] [Abstract][Full Text] [Related]
9. Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/L. Chong PP; van Duin D; Bangdiwala A; Ivanova A; Miller WC; Weber DJ; Gilligan PH; Shea TC Clin Ther; 2016 Nov; 38(11):2468-2476. PubMed ID: 27771176 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients. Britt NS; Potter EM; Patel N; Steed ME Clin Infect Dis; 2015 Sep; 61(6):871-8. PubMed ID: 26063715 [TBL] [Abstract][Full Text] [Related]
20. Impact of Enterococcal Bacteremia in Liver Transplant Recipients. Kim YJ; Jun YH; Choi HJ; You YK; Kim DG; Choi JY; Yoon SK; Kim SI Transplant Proc; 2019 Oct; 51(8):2766-2770. PubMed ID: 31493916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]